JP2023552829A5 - - Google Patents
Info
- Publication number
- JP2023552829A5 JP2023552829A5 JP2023534951A JP2023534951A JP2023552829A5 JP 2023552829 A5 JP2023552829 A5 JP 2023552829A5 JP 2023534951 A JP2023534951 A JP 2023534951A JP 2023534951 A JP2023534951 A JP 2023534951A JP 2023552829 A5 JP2023552829 A5 JP 2023552829A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- cdr
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063123387P | 2020-12-09 | 2020-12-09 | |
| US63/123,387 | 2020-12-09 | ||
| US202163169604P | 2021-04-01 | 2021-04-01 | |
| US63/169,604 | 2021-04-01 | ||
| PCT/US2021/062485 WO2022125712A1 (en) | 2020-12-09 | 2021-12-08 | Fusions of mutant interleukin-10 polypeptides with antigen binding molecules for modulating immune cell function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023552829A JP2023552829A (ja) | 2023-12-19 |
| JP2023552829A5 true JP2023552829A5 (https=) | 2024-12-17 |
Family
ID=81973973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023534951A Pending JP2023552829A (ja) | 2020-12-09 | 2021-12-08 | 免疫細胞機能を調節するための変異インターロイキン－１０ポリペプチドの抗原結合分子との融合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240010695A1 (https=) |
| EP (1) | EP4259645A4 (https=) |
| JP (1) | JP2023552829A (https=) |
| KR (1) | KR20230129423A (https=) |
| AU (1) | AU2021396247A1 (https=) |
| CA (1) | CA3204723A1 (https=) |
| TW (1) | TW202237630A (https=) |
| WO (1) | WO2022125712A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230112632A (ko) * | 2020-10-23 | 2023-07-27 | 애셔 바이오테라퓨틱스, 인크. | 면역 세포 기능을 조절하기 위한 cd8 항원 결합 분자와의 융합 |
| IL308609A (en) | 2021-05-19 | 2024-01-01 | Asher Biotherapeutics Inc | IL-21 polypeptides and target constructs |
| CN118206629B (zh) * | 2022-12-16 | 2025-12-02 | 深圳莱芒生物科技有限公司 | 一种细胞因子白细胞介素10的突变体及其制备方法和应用 |
| CN118240058A (zh) * | 2022-12-24 | 2024-06-25 | 广东菲鹏制药股份有限公司 | Il10突变体、融合蛋白和药物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001058950A1 (en) * | 2000-02-11 | 2001-08-16 | Maxygen Aps | Improved interleukin 10 |
| AU2003280315A1 (en) * | 2002-11-14 | 2004-06-03 | Maxygen, Inc. | Conjugates of interleukin-10 and polymers |
| WO2015117930A1 (en) * | 2014-02-06 | 2015-08-13 | F. Hoffmann-La Roche Ag | Interleukine 10 immunoconjugates |
| CR20200327A (es) * | 2018-01-26 | 2020-11-05 | Genentech Inc | Proteínas de fusión fc il-22 y métodos de uso |
| JP2022512746A (ja) * | 2018-10-19 | 2022-02-07 | アンブルックス，インコーポレイテッド | インターロイキン－１０ポリペプチド複合体、その二量体、およびそれらの使用 |
| SG11202102930YA (en) * | 2018-11-08 | 2021-04-29 | Synthorx Inc | Interleukin 10 conjugates and uses thereof |
| EP3927728A2 (en) * | 2019-02-21 | 2021-12-29 | Xencor, Inc. | Untargeted and targeted il-10 fc-fusion proteins |
-
2021
- 2021-12-08 CA CA3204723A patent/CA3204723A1/en active Pending
- 2021-12-08 US US18/039,608 patent/US20240010695A1/en active Pending
- 2021-12-08 AU AU2021396247A patent/AU2021396247A1/en active Pending
- 2021-12-08 KR KR1020237022767A patent/KR20230129423A/ko active Pending
- 2021-12-08 JP JP2023534951A patent/JP2023552829A/ja active Pending
- 2021-12-08 WO PCT/US2021/062485 patent/WO2022125712A1/en not_active Ceased
- 2021-12-08 EP EP21904357.7A patent/EP4259645A4/en active Pending
- 2021-12-09 TW TW110146126A patent/TW202237630A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023552829A5 (https=) | ||
| JP2023548045A5 (https=) | ||
| JP2023085476A5 (https=) | ||
| JP2018537966A5 (https=) | ||
| WO2022087458A1 (en) | Fusions with cd8 antigen binding molecules for modulating immune cell function | |
| JP2021522162A5 (https=) | ||
| CN111936514A (zh) | 多价抗体 | |
| JP2021533779A5 (https=) | ||
| JP2021521781A5 (https=) | ||
| JP2025165930A (ja) | Ｇｉｐｒ抗体及びｇｌｐ－１とのその融合タンパク質、並びにその医薬組成物及び用途 | |
| JP2024522069A5 (https=) | ||
| US20240010695A1 (en) | Fusions of mutant interleukin-10 polypeptides with antigen binding molecules for modulating immune cell function | |
| JP2023524132A5 (https=) | ||
| CA3184746A1 (en) | Anti-pd-1 antibodies and fusion proteins | |
| JP2022513321A5 (https=) | ||
| JP2024534783A5 (https=) | ||
| US20250339519A1 (en) | Combination of cytokine fusion proteins with cd8 antigen binding molecules | |
| CN120112558A (zh) | 治疗慢性病毒感染的含cd8抗原结合分子的融合物 | |
| CN116829577A (zh) | 用于调节免疫细胞功能的突变型白介素-10多肽与抗原结合分子的融合物 | |
| WO2023186112A1 (zh) | 靶向ceacam和cd3的多特异性抗体及其用途 | |
| JP2024532426A5 (https=) | ||
| JP2022537736A5 (https=) | ||
| RU2021102799A (ru) | Антитела, содержащие полипептид, встроенный в участок каркасной области 3 | |
| NZ807450A (en) | Antibodies binding to gprc5d | |
| RU2022104485A (ru) | Антитела, связывающиеся с gprc5d |